Cargando…

Thymosin a1 use is not associated with reduced COVID-19 mortality

Detalles Bibliográficos
Autores principales:	Liu, Tao, Liu, Shengdong, Li, Tao, Zhang, Jingjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053599/ https://www.ncbi.nlm.nih.gov/pubmed/33896653 http://dx.doi.org/10.1016/j.ajem.2021.04.043

Ejemplares similares

Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study
por: Liu, Jiao, et al.
Publicado: (2021)

The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study
por: Sun, Qin, et al.
Publicado: (2021)

Gender-associated difference following COVID-19 virus infection: Implications for thymosin alpha-1 therapy
por: Li, Xin, et al.
Publicado: (2021)

Thymosin α1 for COVID-19: Look before You Leap!
por: Divatia, Jigeeshu V
Publicado: (2022)

Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients
por: Wang, Zhenyan, et al.
Publicado: (2021)

Thymosin Beta 4 and Thymosin Beta 10 Expression in Hepatocellular Carcinoma
por: Theunissen, W., et al.
Publicado: (2014)

COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections
por: Bellet, Marina M., et al.
Publicado: (2023)

Thymosin alpha1 use in adult COVID-19 patients: A systematic review and meta-analysis on clinical outcomes
por: Shang, Weifeng, et al.
Publicado: (2023)

Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study
por: Wu, Ming, et al.
Publicado: (2020)

Effect of thymalfasin (Thymosin-α-1) on reversing lymphocytopenia among patients with COVID-19
por: Benitez, Gregorio, et al.
Publicado: (2023)

Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure
por: Yang, Xueliang, et al.
Publicado: (2018)

Thymosin as a possible therapeutic drug for COVID-19: A case report
por: Zheng, Qiong Na, et al.
Publicado: (2021)

Thymosin Beta 15 Alters the Spatial Development of Thymic Epithelial Cells
por: Xu, Xie, et al.
Publicado: (2022)

Thymosin alpha 1: Biological activities, applications and genetic engineering production
por: Li, Juan, et al.
Publicado: (2010)

Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease
por: Jiang, Yong, et al.
Publicado: (2017)

A Reappraisal of Thymosin Alpha1 in Cancer Therapy
por: Costantini, Claudio, et al.
Publicado: (2019)

Thymosin alpha 1: A comprehensive review of the literature
por: Dominari, Asimina, et al.
Publicado: (2020)

Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application
por: Tao, Nana, et al.
Publicado: (2023)

Immunoreactivity for Thymosin Beta 4 and Thymosin Beta 10 in the Adult Rat Oro-Gastro-Intestinal tract
por: Nemolato, S, et al.
Publicado: (2013)

Thymosin Beta-4 Induces Mouse Hair Growth
por: Gao, Xiaoyu, et al.
Publicado: (2015)

Overexpression of thymosin β10 correlates with disease progression and poor prognosis in bladder cancer
por: Wang, Bingwei, et al.
Publicado: (2019)

Mechanism and clinical application of thymosin in the treatment of lung cancer
por: Liu, Yafeng, et al.
Publicado: (2023)

Expression and Hydroxylamine Cleavage of Thymosin Alpha 1 Concatemer
por: Zhou, Liang, et al.
Publicado: (2008)

Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro
por: Yang, Xia, et al.
Publicado: (2011)

Progress on the Function and Application of Thymosin β4
por: Xing, Yuan, et al.
Publicado: (2021)

β-Thymosins and Hemocyte Homeostasis in a Crustacean
por: Saelee, Netnapa, et al.
Publicado: (2013)

The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2
por: Espinar-Buitrago, M. S., et al.
Publicado: (2023)

Construction, Expression, and Characterization of Thymosin Alpha 1 Tandem Repeats in Escherichia coli
por: Xue, Xiao-Chang, et al.
Publicado: (2013)

Potential Role of Thymosin-α1 Adjuvant Therapy for Glioblastoma
por: Sungarian, Arno, et al.
Publicado: (2009)

A Tumor-Penetrating Peptide Modification Enhances the Antitumor Activity of Thymosin Alpha 1
por: Lao, Xingzhen, et al.
Publicado: (2013)

The right immune-modulation at the right time: thymosin α1 for prevention of severe COVID-19 in cancer patients
por: Bersanelli, Melissa, et al.
Publicado: (2021)

The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease
por: Liang, Jing, et al.
Publicado: (2016)

Production of N(α)-acetylated thymosin α1 in Escherichia coli
por: Ren, Yuantao, et al.
Publicado: (2011)

Thymosin Beta 4 Is Involved in the Development of Electroacupuncture Tolerance
por: Wan, Juan, et al.
Publicado: (2019)

Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection
por: Yu, Rui, et al.
Publicado: (2021)

Thymosin β 10 is overexpressed and associated with unfavorable prognosis in hepatocellular carcinoma
por: Song, Chunrong, et al.
Publicado: (2019)

The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials
por: Liu, Fang, et al.
Publicado: (2016)

Thymosin α1 protects from CTLA-4 intestinal immunopathology
por: Renga, Giorgia, et al.
Publicado: (2020)

Protection effect of thymosin β4 on ethanol injury in corneal stromal keratocyte
por: Liu, Jinghua, et al.
Publicado: (2022)

Vitamin AD Drops are More Effective than Intramuscular Injection of Thymosin in Reducing the Rate of Growth Retardation in Children
por: Luo, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j08k80ajbg88ssb57qrcvpg490